Next Article in Journal
Ceftazidime–Avibactam Use in a Case Series of Difficult-to-Treat or Recurrent Infections in Pediatric Patients with Complex Chronic Conditions: Effectiveness and Absence of Resistance Development
Next Article in Special Issue
Duration of Antibiotic Treatment for Foot Osteomyelitis in People with Diabetes
Previous Article in Journal
New Insights into Pseudomonas spp.-Produced Antibiotics: Genetic Regulation of Biosynthesis and Implementation in Biotechnology
Previous Article in Special Issue
Staphylococcus aureus Is the Predominant Pathogen in Hospitalised Patients with Diabetes-Related Foot Infections: An Australian Perspective
 
 
Article

Article Versions Notes

Antibiotics 2024, 13(7), 599; https://doi.org/10.3390/antibiotics13070599
Action Date Notes Link
article xml file uploaded 27 June 2024 08:37 CEST Original file -
article xml uploaded. 27 June 2024 08:37 CEST Update https://www.mdpi.com/2079-6382/13/7/599/xml
article pdf uploaded. 27 June 2024 08:37 CEST Version of Record https://www.mdpi.com/2079-6382/13/7/599/pdf
article html file updated 27 June 2024 08:39 CEST Original file https://www.mdpi.com/2079-6382/13/7/599/html
Back to TopTop